ONCOCOMPLETE
DEAD

Serial Number

97833340

Owner

Exact Sciences Corporation

Attorney

Sana Hakim

Filing Date

Mar 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ONCOCOMPLETE Trademark

Serial Number: 97833340

ONCOCOMPLETE is a trademark filed by Exact Sciences Corporation on March 10, 2023. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Exact Sciences Corporation (126 trademarks)

441 Charmany Drive
Madison, WI 53719

Entity Type: 03

Trademark Details

Filing Date

March 10, 2023

Registration Date

Not Registered

Published for Opposition

October 10, 2023

Goods & Services

Providing a website featuring resources, namely, non-downloadable videos and publications in the nature of newsletters and articles in the field of cancer; Providing an internet website portal featuring non-downloadable educational videos and webcasts in the field of cancer

Providing medical information to medical professionals and healthcare providers in the form of reports in the field of cancer screening, diagnostics, prognostics and treatment; Providing information to patients in the field of medical diagnostic screening; Providing medical information in the field of cancer awareness; Providing information in the field of prevention, screening, diagnosis, and treatment of cancer; Providing information to patients, medical professionals and healthcare providers in the field of medical diagnostic screening; Providing medical information; Providing a web site featuring medical information; Providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing in the field of cancer; Providing genomic and genetic testing for medical purposes in the field of cancer; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer; Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes and copy number variations for hereditary cancer, identification of hereditary risk associated with cancer and identification of predisposition to cancer

Platform as a service (PAAS) services featuring a computer software platform that allows patients to communicate with healthcare providers, doctors, and physicians, access on-demand phone support, and receive reminder phone calls, texts and emails in the field of cancer screening, pre-cancer screening, cancer diagnostic testing, disease or pre-disease detection, monitoring or surveillance; Providing temporary online use of non-downloadable software for use by physicians for use in collecting, requesting, managing, analyzing and comparing medical information, patient records, patient laboratory orders, patient tests and analysis; Providing an online website portal featuring technology that allows users to register and access the test results associated with medical and diagnostic test kits for detecting cancer; all of the foregoing for use in the field of cancer diagnostics, prognostics and treatment recommendations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
SOU EXTENSION 1 GRANTED
May 24, 2024 EX1G
SOU EXTENSION 1 FILED
May 24, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 24, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 31, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 31, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 31, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 31, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 25, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 11, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 19, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2023 NWOS
NEW APPLICATION ENTERED
Mar 14, 2023 NWAP